APO Research
Talk to an analyst

APO RESEARCH · REPORT

Safety Lancets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Safety Lancets Industry Growth and Trends Forecast to 2032

26 December 2025129 pages

Choose your research edition.

Industry ResearchSafety Lancets Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Safety Lancets Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Safety Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Safety Lancets Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Safety Lancets Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Safety Lancets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Safety Lancets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Safety Lancets include Tianjin Huahong, SteriLance Medical, Shandong Lianfa, Roche, Guangzhou iCare Medical, B. Braun, UltiMed, Terumo and Sarstedt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Safety Lancets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Safety Lancets market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Safety Lancets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Safety Lancets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Safety Lancets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Safety Lancets Market by Company

Tianjin Huahong

SteriLance Medical

Shandong Lianfa

Roche

Guangzhou iCare Medical

B. Braun

UltiMed

Terumo

Sarstedt

Owen Mumford

Nipro

Lifescan

ICU Medical

HTL-STREFA

HemoCue

Greiner Bio One

Cardinal Health

BD

Ascensia

ARKRAY

Safety Lancets Segment by Type

Safety Lancets with Needle

Safety Lancets with Blade

Safety Lancets Segment by Application

Hospital & Clinics

Home

Other

Safety Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Safety Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Safety Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Safety Lancets with Needle Table 2. Major Company of Safety Lancets with Blade Table 3. Global Safety Lancets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Safety Lancets Sales by Type (2021-2026) & (M Units) Table 5. Global Safety Lancets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Safety Lancets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Safety Lancets Sales Market Share in Value by Type (2021-2026) Table 8. Global Safety Lancets Price by Type (2021-2026) & (US$/K Unit) Table 9. Global Safety Lancets Sales by Type (2027-2032) & (M Units) Table 10. Global Safety Lancets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Safety Lancets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Safety Lancets Sales Market Share in Value by Type (2027-2032) Table 13. Global Safety Lancets Price by Type (2027-2032) & (US$/K Unit) Table 14. North America Safety Lancets Sales by Type (2021-2026) & (M Units) Table 15. North America Safety Lancets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Safety Lancets Sales by Type (2021-2026) & (M Units) Table 17. Europe Safety Lancets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Safety Lancets Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Safety Lancets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Safety Lancets Sales by Type (2021-2026) & (M Units) Table 21. Latin America Safety Lancets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Safety Lancets Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Safety Lancets Sales by Type (2021-2026) & (US$ Million) Table 24. Safety Lancets Industry Trends Table 25. Safety Lancets Industry Drivers Table 26. Safety Lancets Industry Opportunities and Challenges Table 27. Safety Lancets Industry Restraints Table 28. Global Safety Lancets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Safety Lancets Revenue Market Share by Company (2021-2026) Table 30. Global Safety Lancets Sales by Company (2021-2026) & (M Units) Table 31. Global Safety Lancets Sales Share by Company (2021-2026) Table 32. Global Safety Lancets Market Price by Company (2021-2026) & (US$/K Unit) Table 33. Global Safety Lancets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Safety Lancets Major Company Production Sites and Headquarters Table 35. Global Safety Lancets Company, Product Type & Application Table 36. Global Safety Lancets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Safety Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Safety Lancets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Safety Lancets Sales by Region (2021-2026) & (M Units) Table 41. Global Safety Lancets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Safety Lancets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Safety Lancets Sales Market Share in Value by Region (2021-2026) Table 44. Global Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 45. Global Safety Lancets Sales by Region (2027-2032) & (M Units) Table 46. Global Safety Lancets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Safety Lancets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Safety Lancets Sales Market Share in Value by Region (2027-2032) Table 49. Global Safety Lancets Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2027-2032) Table 50. Global Safety Lancets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Safety Lancets Sales by Application (2021-2026) & (M Units) Table 52. Global Safety Lancets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Safety Lancets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Safety Lancets Sales Market Share in Value by Application (2021-2026) Table 55. Global Safety Lancets Price by Application (2021-2026) & (US$/K Unit) Table 56. Global Safety Lancets Sales by Application (2027-2032) & (M Units) Table 57. Global Safety Lancets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Safety Lancets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Safety Lancets Sales Market Share in Value by Application (2027-2032) Table 60. Global Safety Lancets Price by Application (2027-2032) & (US$/K Unit) Table 61. North America Safety Lancets Sales by Application (2021-2026) & (M Units) Table 62. North America Safety Lancets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Safety Lancets Sales by Application (2021-2026) & (M Units) Table 64. Europe Safety Lancets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Safety Lancets Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Safety Lancets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Safety Lancets Sales by Application (2021-2026) & (M Units) Table 68. Latin America Safety Lancets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Safety Lancets Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Safety Lancets Sales by Application (2021-2026) & (US$ Million) Table 71. Tianjin Huahong Company Information Table 72. Tianjin Huahong Business Overview Table 73. Tianjin Huahong Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 74. Tianjin Huahong Safety Lancets Product Portfolio Table 75. Tianjin Huahong Recent Development Table 76. SteriLance Medical Company Information Table 77. SteriLance Medical Business Overview Table 78. SteriLance Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 79. SteriLance Medical Safety Lancets Product Portfolio Table 80. SteriLance Medical Recent Development Table 81. Shandong Lianfa Company Information Table 82. Shandong Lianfa Business Overview Table 83. Shandong Lianfa Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 84. Shandong Lianfa Safety Lancets Product Portfolio Table 85. Shandong Lianfa Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 89. Roche Safety Lancets Product Portfolio Table 90. Roche Recent Development Table 91. Guangzhou iCare Medical Company Information Table 92. Guangzhou iCare Medical Business Overview Table 93. Guangzhou iCare Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 94. Guangzhou iCare Medical Safety Lancets Product Portfolio Table 95. Guangzhou iCare Medical Recent Development Table 96. B. Braun Company Information Table 97. B. Braun Business Overview Table 98. B. Braun Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 99. B. Braun Safety Lancets Product Portfolio Table 100. B. Braun Recent Development Table 101. UltiMed Company Information Table 102. UltiMed Business Overview Table 103. UltiMed Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 104. UltiMed Safety Lancets Product Portfolio Table 105. UltiMed Recent Development Table 106. Terumo Company Information Table 107. Terumo Business Overview Table 108. Terumo Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 109. Terumo Safety Lancets Product Portfolio Table 110. Terumo Recent Development Table 111. Sarstedt Company Information Table 112. Sarstedt Business Overview Table 113. Sarstedt Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 114. Sarstedt Safety Lancets Product Portfolio Table 115. Sarstedt Recent Development Table 116. Owen Mumford Company Information Table 117. Owen Mumford Business Overview Table 118. Owen Mumford Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 119. Owen Mumford Safety Lancets Product Portfolio Table 120. Owen Mumford Recent Development Table 121. Nipro Company Information Table 122. Nipro Business Overview Table 123. Nipro Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 124. Nipro Safety Lancets Product Portfolio Table 125. Nipro Recent Development Table 126. Lifescan Company Information Table 127. Lifescan Business Overview Table 128. Lifescan Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 129. Lifescan Safety Lancets Product Portfolio Table 130. Lifescan Recent Development Table 131. ICU Medical Company Information Table 132. ICU Medical Business Overview Table 133. ICU Medical Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 134. ICU Medical Safety Lancets Product Portfolio Table 135. ICU Medical Recent Development Table 136. HTL-STREFA Company Information Table 137. HTL-STREFA Business Overview Table 138. HTL-STREFA Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 139. HTL-STREFA Safety Lancets Product Portfolio Table 140. HTL-STREFA Recent Development Table 141. HemoCue Company Information Table 142. HemoCue Business Overview Table 143. HemoCue Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 144. HemoCue Safety Lancets Product Portfolio Table 145. HemoCue Recent Development Table 146. Greiner Bio One Company Information Table 147. Greiner Bio One Business Overview Table 148. Greiner Bio One Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 149. Greiner Bio One Safety Lancets Product Portfolio Table 150. Greiner Bio One Recent Development Table 151. Cardinal Health Company Information Table 152. Cardinal Health Business Overview Table 153. Cardinal Health Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 154. Cardinal Health Safety Lancets Product Portfolio Table 155. Cardinal Health Recent Development Table 156. BD Company Information Table 157. BD Business Overview Table 158. BD Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 159. BD Safety Lancets Product Portfolio Table 160. BD Recent Development Table 161. Ascensia Company Information Table 162. Ascensia Business Overview Table 163. Ascensia Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 164. Ascensia Safety Lancets Product Portfolio Table 165. Ascensia Recent Development Table 166. ARKRAY Company Information Table 167. ARKRAY Business Overview Table 168. ARKRAY Safety Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 169. ARKRAY Safety Lancets Product Portfolio Table 170. ARKRAY Recent Development Table 171. North America Safety Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 172. North America Safety Lancets Sales by Country (2021-2026) & (M Units) Table 173. North America Safety Lancets Sales Market Share by Country (2021-2026) Table 174. North America Safety Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 175. North America Safety Lancets Sales Market Share Forecast by Country (2027-2032) Table 176. North America Safety Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Safety Lancets Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Safety Lancets Market Share by Country (2021-2026) Table 179. North America Safety Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Safety Lancets Market Share Forecast by Country (2027-2032) Table 181. Europe Safety Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 182. Europe Safety Lancets Sales by Country (2021-2026) & (M Units) Table 183. Europe Safety Lancets Sales Market Share by Country (2021-2026) Table 184. Europe Safety Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 185. Europe Safety Lancets Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Safety Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Safety Lancets Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Safety Lancets Market Share by Country (2021-2026) Table 189. Europe Safety Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Safety Lancets Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Safety Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Safety Lancets Sales by Country (2021-2026) & (M Units) Table 193. Asia-Pacific Safety Lancets Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Safety Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 195. Asia-Pacific Safety Lancets Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Safety Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Safety Lancets Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Safety Lancets Market Share by Country (2021-2026) Table 199. Asia-Pacific Safety Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Safety Lancets Market Share Forecast by Country (2027-2032) Table 201. Latin America Safety Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 202. Latin America Safety Lancets Sales by Country (2021-2026) & (M Units) Table 203. Latin America Safety Lancets Sales Market Share by Country (2021-2026) Table 204. Latin America Safety Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 205. Latin America Safety Lancets Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Safety Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Safety Lancets Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Safety Lancets Market Share by Country (2021-2026) Table 209. Latin America Safety Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Safety Lancets Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Safety Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Safety Lancets Sales by Country (2021-2026) & (M Units) Table 213. Middle East and Africa Safety Lancets Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Safety Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 215. Middle East and Africa Safety Lancets Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Safety Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Safety Lancets Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Safety Lancets Market Share by Country (2021-2026) Table 219. Middle East and Africa Safety Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Safety Lancets Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Safety Lancets Distributors List Table 224. Safety Lancets Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Safety Lancets Image Figure 2. Global Safety Lancets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Safety Lancets Market Size (2021-2032) & (US$ Million) Figure 4. Global Safety Lancets Sales (2021-2032) & (M Units) Figure 5. Safety Lancets with Needle Image Figure 6. Global Safety Lancets with Needle Sales YoY Growth (2021-2032) & (M Units) Figure 7. Safety Lancets with Blade Image Figure 8. Global Safety Lancets with Blade Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Safety Lancets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Safety Lancets Market Share by Type 2025 VS 2032 Figure 11. North America Safety Lancets Sales Market Share in Volume by Type in 2025 Figure 12. North America Safety Lancets Sales Market Share in Value by Type in 2025 Figure 13. Europe Safety Lancets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Safety Lancets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Safety Lancets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Safety Lancets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Safety Lancets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Safety Lancets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Safety Lancets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Safety Lancets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Safety Lancets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital & Clinics Image Figure 24. Global Hospital & Clinics Sales YoY Growth (2021-2032) & (M Units) Figure 25. Home Image Figure 26. Global Home Sales YoY Growth (2021-2032) & (M Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Safety Lancets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Safety Lancets Market Share by Application 2025 VS 2032 Figure 31. North America Safety Lancets Sales Market Share in Volume by Application in 2025 Figure 32. North America Safety Lancets Sales Market Share in Value by Application in 2025 Figure 33. Europe Safety Lancets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Safety Lancets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Safety Lancets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Safety Lancets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Safety Lancets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Safety Lancets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Safety Lancets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Safety Lancets Sales Market Share in Value by Application in 2025 Figure 41. North America Safety Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Safety Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Safety Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Safety Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Safety Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Safety Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Safety Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Safety Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Safety Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Safety Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Safety Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Safety Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Safety Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Safety Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Safety Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Safety Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Safety Lancets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Safety Lancets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Lancets with Needle
  • Safety Lancets with Blade
Applications
  • Hospital & Clinics
  • Home
  • Other
Companies covered
  • Tianjin Huahong
  • SteriLance Medical
  • Shandong Lianfa
  • Roche
  • Guangzhou iCare Medical
  • B. Braun
  • UltiMed
  • Terumo
  • Sarstedt
  • Owen Mumford
  • Nipro
  • Lifescan
  • ICU Medical
  • HTL-STREFA
  • HemoCue
  • Greiner Bio One
  • Cardinal Health
  • BD
  • Ascensia
  • ARKRAY

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Safety Lancets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Safety Lancets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Safety Lancets Market by Type
  6. 1.3.1 Safety Lancets with Needle
  7. 1.3.2 Safety Lancets with Blade
  8. 1.4 Global Safety Lancets Market Size by Type
  9. 1.4.1 Global Safety Lancets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Safety Lancets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Safety Lancets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Safety Lancets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Safety Lancets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Safety Lancets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Safety Lancets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Safety Lancets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Safety Lancets Industry Trends
  2. 2.2 Safety Lancets Industry Drivers
  3. 2.3 Safety Lancets Industry Opportunities and Challenges
  4. 2.4 Safety Lancets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Safety Lancets Revenue (2021-2026)
  2. 3.2 Global Top Players by Safety Lancets Sales (2021-2026)
  3. 3.3 Global Top Players by Safety Lancets Price (2021-2026)
  4. 3.4 Global Safety Lancets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Safety Lancets Major Company Production Sites & Headquarters
  6. 3.6 Global Safety Lancets Company, Product Type & Application
  7. 3.7 Global Safety Lancets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Safety Lancets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Safety Lancets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Safety Lancets Tier 1, Tier 2, and Tier 3
4 Safety Lancets Regional Status and Outlook
  1. 4.1 Global Safety Lancets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Safety Lancets Historic Market Size by Region
  3. 4.2.1 Global Safety Lancets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Safety Lancets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Safety Lancets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Safety Lancets Forecasted Market Size by Region
  7. 4.3.1 Global Safety Lancets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Safety Lancets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Safety Lancets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Safety Lancets by Application
  1. 5.1 Safety Lancets Market by Application
  2. 5.1.1 Hospital & Clinics
  3. 5.1.2 Home
  4. 5.1.3 Other
  5. 5.2 Global Safety Lancets Market Size by Application
  6. 5.2.1 Global Safety Lancets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Safety Lancets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Safety Lancets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Safety Lancets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Safety Lancets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Safety Lancets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Safety Lancets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Safety Lancets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tianjin Huahong
  2. 6.1.1 Tianjin Huahong Company Information
  3. 6.1.2 Tianjin Huahong Business Overview
  4. 6.1.3 Tianjin Huahong Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tianjin Huahong Safety Lancets Product Portfolio
  6. 6.1.5 Tianjin Huahong Recent Developments
  7. 6.2 SteriLance Medical
  8. 6.2.1 SteriLance Medical Company Information
  9. 6.2.2 SteriLance Medical Business Overview
  10. 6.2.3 SteriLance Medical Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SteriLance Medical Safety Lancets Product Portfolio
  12. 6.2.5 SteriLance Medical Recent Developments
  13. 6.3 Shandong Lianfa
  14. 6.3.1 Shandong Lianfa Company Information
  15. 6.3.2 Shandong Lianfa Business Overview
  16. 6.3.3 Shandong Lianfa Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong Lianfa Safety Lancets Product Portfolio
  18. 6.3.5 Shandong Lianfa Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Safety Lancets Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Guangzhou iCare Medical
  26. 6.5.1 Guangzhou iCare Medical Company Information
  27. 6.5.2 Guangzhou iCare Medical Business Overview
  28. 6.5.3 Guangzhou iCare Medical Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guangzhou iCare Medical Safety Lancets Product Portfolio
  30. 6.5.5 Guangzhou iCare Medical Recent Developments
  31. 6.6 B. Braun
  32. 6.6.1 B. Braun Company Information
  33. 6.6.2 B. Braun Business Overview
  34. 6.6.3 B. Braun Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 B. Braun Safety Lancets Product Portfolio
  36. 6.6.5 B. Braun Recent Developments
  37. 6.7 UltiMed
  38. 6.7.1 UltiMed Company Information
  39. 6.7.2 UltiMed Business Overview
  40. 6.7.3 UltiMed Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 UltiMed Safety Lancets Product Portfolio
  42. 6.7.5 UltiMed Recent Developments
  43. 6.8 Terumo
  44. 6.8.1 Terumo Company Information
  45. 6.8.2 Terumo Business Overview
  46. 6.8.3 Terumo Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Terumo Safety Lancets Product Portfolio
  48. 6.8.5 Terumo Recent Developments
  49. 6.9 Sarstedt
  50. 6.9.1 Sarstedt Company Information
  51. 6.9.2 Sarstedt Business Overview
  52. 6.9.3 Sarstedt Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sarstedt Safety Lancets Product Portfolio
  54. 6.9.5 Sarstedt Recent Developments
  55. 6.10 Owen Mumford
  56. 6.10.1 Owen Mumford Company Information
  57. 6.10.2 Owen Mumford Business Overview
  58. 6.10.3 Owen Mumford Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Owen Mumford Safety Lancets Product Portfolio
  60. 6.10.5 Owen Mumford Recent Developments
  61. 6.11 Nipro
  62. 6.11.1 Nipro Company Information
  63. 6.11.2 Nipro Business Overview
  64. 6.11.3 Nipro Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nipro Safety Lancets Product Portfolio
  66. 6.11.5 Nipro Recent Developments
  67. 6.12 Lifescan
  68. 6.12.1 Lifescan Company Information
  69. 6.12.2 Lifescan Business Overview
  70. 6.12.3 Lifescan Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Lifescan Safety Lancets Product Portfolio
  72. 6.12.5 Lifescan Recent Developments
  73. 6.13 ICU Medical
  74. 6.13.1 ICU Medical Company Information
  75. 6.13.2 ICU Medical Business Overview
  76. 6.13.3 ICU Medical Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ICU Medical Safety Lancets Product Portfolio
  78. 6.13.5 ICU Medical Recent Developments
  79. 6.14 HTL-STREFA
  80. 6.14.1 HTL-STREFA Company Information
  81. 6.14.2 HTL-STREFA Business Overview
  82. 6.14.3 HTL-STREFA Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 HTL-STREFA Safety Lancets Product Portfolio
  84. 6.14.5 HTL-STREFA Recent Developments
  85. 6.15 HemoCue
  86. 6.15.1 HemoCue Company Information
  87. 6.15.2 HemoCue Business Overview
  88. 6.15.3 HemoCue Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 HemoCue Safety Lancets Product Portfolio
  90. 6.15.5 HemoCue Recent Developments
  91. 6.16 Greiner Bio One
  92. 6.16.1 Greiner Bio One Company Information
  93. 6.16.2 Greiner Bio One Business Overview
  94. 6.16.3 Greiner Bio One Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Greiner Bio One Safety Lancets Product Portfolio
  96. 6.16.5 Greiner Bio One Recent Developments
  97. 6.17 Cardinal Health
  98. 6.17.1 Cardinal Health Company Information
  99. 6.17.2 Cardinal Health Business Overview
  100. 6.17.3 Cardinal Health Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Cardinal Health Safety Lancets Product Portfolio
  102. 6.17.5 Cardinal Health Recent Developments
  103. 6.18 BD
  104. 6.18.1 BD Company Information
  105. 6.18.2 BD Business Overview
  106. 6.18.3 BD Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 BD Safety Lancets Product Portfolio
  108. 6.18.5 BD Recent Developments
  109. 6.19 Ascensia
  110. 6.19.1 Ascensia Company Information
  111. 6.19.2 Ascensia Business Overview
  112. 6.19.3 Ascensia Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Ascensia Safety Lancets Product Portfolio
  114. 6.19.5 Ascensia Recent Developments
  115. 6.20 ARKRAY
  116. 6.20.1 ARKRAY Company Information
  117. 6.20.2 ARKRAY Business Overview
  118. 6.20.3 ARKRAY Safety Lancets Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 ARKRAY Safety Lancets Product Portfolio
  120. 6.20.5 ARKRAY Recent Developments
7 North America by Country
  1. 7.1 North America Safety Lancets Sales by Country
  2. 7.1.1 North America Safety Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Safety Lancets Sales by Country (2021-2026)
  4. 7.1.3 North America Safety Lancets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Safety Lancets Market Size by Country
  6. 7.2.1 North America Safety Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Safety Lancets Market Size by Country (2021-2026)
  8. 7.2.3 North America Safety Lancets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Safety Lancets Sales by Country
  2. 8.1.1 Europe Safety Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Safety Lancets Sales by Country (2021-2026)
  4. 8.1.3 Europe Safety Lancets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Safety Lancets Market Size by Country
  6. 8.2.1 Europe Safety Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Safety Lancets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Safety Lancets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Safety Lancets Sales by Country
  2. 9.1.1 Asia-Pacific Safety Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Safety Lancets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Safety Lancets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Safety Lancets Market Size by Country
  6. 9.2.1 Asia-Pacific Safety Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Safety Lancets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Safety Lancets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Safety Lancets Sales by Country
  2. 10.1.1 South America Safety Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Safety Lancets Sales by Country (2021-2026)
  4. 10.1.3 South America Safety Lancets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Safety Lancets Market Size by Country
  6. 10.2.1 South America Safety Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Safety Lancets Market Size by Country (2021-2026)
  8. 10.2.3 South America Safety Lancets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Safety Lancets Sales by Country
  2. 11.1.1 Middle East and Africa Safety Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Safety Lancets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Safety Lancets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Safety Lancets Market Size by Country
  6. 11.2.1 Middle East and Africa Safety Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Safety Lancets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Safety Lancets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Safety Lancets Value Chain Analysis
  2. 12.1.1 Safety Lancets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Safety Lancets Production Mode & Process
  7. 12.2 Safety Lancets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Safety Lancets Distributors
  10. 12.2.3 Safety Lancets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst